Baole Wang
Impact in
-
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Cancer therapeutics and mechanisms
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Cancer therapeutics and mechanisms 3
- Angiogenesis and VEGF in Cancer 1
- Oncology 4
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Saul H. Rosenberg (3 shared papers)Steven W. Elmore (3 shared papers)Alex R. Shoemaker (3 shared papers)Marion Refici (2 shared papers)Stephen W. Fesik (3 shared papers)Joy Bauch (2 shared papers)Anatol Oleksijew (3 shared papers)Michael J. Mitten (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Energy Reports (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Baole Wang
6 papers receiving 223 citations
Peers
Comparison fields: 5 of 45
- Oncology 92
- Molecular Biology 184
- Genetics 23
- Pathology and Forensic Medicine 33
- Immunology 31
Countries citing papers authored by Baole Wang
This map shows the geographic impact of Baole Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baole Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baole Wang more than expected).
Fields of papers citing papers by Baole Wang
This network shows the impact of papers produced by Baole Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baole Wang. The network helps show where Baole Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Baole Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 155 | |
| 2 | 2008 | 64 | |
| 3 | 2020 | 3 | |
| 4 | The RTK inhibitor ABT-869, alone and in combination with paclitaxel and/or zoledronic acid, demonstrates significant reduction in the development of both osteoblastic (LuCap 23.1) and osteolytic (PC3-M-Luciferase) tumors intratibially | 2007 | 2 |
| 5 | 2006 | 2 | |
| 6 | The RTK inhibitor, ABT-869 alone or in combination with various cytotoxic therapies demonstrate significant tumor growth inhibition in orthotopic hepatocellular carcinoma, renal cell carcinoma and prostate xenografts | 2007 | 1 |
About Baole Wang
Baole Wang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 6 papers that have together received 227 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Treatment and Pharmacology (1 paper), Prostate Cancer Treatment and Research (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Cancer-related Molecular Pathways (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Oncology (92 citations), Molecular Biology (184 citations), Genetics (23 citations), Pathology and Forensic Medicine (33 citations) and Immunology (31 citations). Baole Wang has collaborated with scholars based in United States and China. Frequent co-authors include Saul H. Rosenberg, Steven W. Elmore, Alex R. Shoemaker, Marion Refici, Stephen W. Fesik, Joy Bauch, Anatol Oleksijew, Michael J. Mitten, Scott Ackler and Christin Tse. Their work appears in journals such as Molecular Cancer Therapeutics, Energy Reports, Clinical Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.